Clearmind Medicine (CMND) Receivables - Net (2021 - 2026)
Clearmind Medicine (CMND) posted quarterly Receivables - Net of $146378.0 for Q2 2026, up 230.58% year-over-year from $44279.0 in Q2 2025, and up 22.13% quarter-over-quarter from $119859.0 in Q1 2026.
Clearmind Medicine (CMND) Receivables - Net (2021 - 2026) Analysis & Trends
Clearmind Medicine's Receivables - Net history runs 6 years deep, the most recent figure standing at $146378.0 for Q2 2026.
- In Q2 2026, Receivables - Net rose 230.58% year-over-year to $146378.0; the TTM figure through Apr 2026 stood at $146378.0 (up 230.58% YoY), while the FY2025 annual figure was $35825.0, down 26.94% from the prior year.
- Receivables - Net for Q2 2026 stood at $146378.0, up from $119859.0 in the prior quarter.
- The five-year high for Receivables - Net was $216360.4 in Q1 2023, with the low at $35825.0 in Q4 2025.
- The 5-year median for Receivables - Net is $69506.0 (2024), against an average of $87360.6.
- The sharpest annual moves came in 2024 and 2026: Receivables - Net plunged 68.34% in 2024, then surged 230.58% in 2026.
- Clearmind Medicine's Receivables - Net stood at $52339.8 in 2022, then soared by 99.31% to $104320.0 in 2023, then sank by 52.99% to $49038.0 in 2024, then declined by 26.94% to $35825.0 in 2025, then surged by 308.59% to $146378.0 in 2026.
- Business Quant data shows CMND's Receivables - Net at $146378.0 in Q2 2026, $119859.0 in Q1 2026, and $35825.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - |
| 10 | Clearmind Medicine | 540,485.35 | -13.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 146,378.00 |
| Apr 30, 2026 | 146,378.00 |
| Jan 31, 2026 | 119,859.00 |
| Jan 31, 2026 | 119,859.00 |
| Oct 31, 2025 | 35,825.00 |
| Oct 31, 2025 | 35,825.00 |
| Jul 31, 2025 | 36,944.00 |
| Jul 31, 2025 | 36,944.00 |
| Apr 30, 2025 | 44,279.00 |
| Apr 30, 2025 | 44,279.00 |
| Jan 31, 2025 | 66,444.00 |
| Jan 31, 2025 | 66,444.00 |
| Oct 31, 2024 | 49,038.00 |
| Oct 31, 2024 | 49,038.00 |
| Jul 31, 2024 | 82,745.00 |
| Jul 31, 2024 | 82,745.00 |
| Apr 30, 2024 | 69,506.00 |
| Apr 30, 2024 | 69,506.00 |
| Jan 31, 2024 | 68,491.00 |
| Jan 31, 2024 | 68,491.00 |